Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
OCI Partners LP
SIC 2800 · Chemicals & Allied Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
OCI Partners LP
SIC 2800 · Chemicals & Allied Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
OCI Partners LP
SIC 2800 · Chemicals & Allied Products
Notes
Support
about
terms
OCI Partners LP
CIK:
0001578932
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.8.0.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]
Revenues
$ 109,758
$ 89,312
Revenues—related party
7,588
3,579
Total Revenue
117,346
92,891
Cost of goods sold (exclusive of depreciation)
49,937
44,888
Cost of goods sold (exclusive of depreciation)—related party
3,721
3,384
Total Cost of goods sold (exclusive of depreciation)
53,658
48,272
Selling, general and administrative expenses
2,844
4,102
Selling, general and administrative expenses—related party
2,260
967
Total Selling, general and administrative expenses
5,104
5,069
Depreciation expense
15,223
15,244
Income from operations before interest expense, other income and income tax expense
43,361
24,306
Interest expense
5,895
5,547
Interest expense—related party
3,468
4,530
Loss on extinguishment of debt
3,501
0
Other expense (income)
6
(19)
Income from operations before tax expense
30,503
14,210
Income tax expense
357
466
Net income
$ 30,146
$ 13,744
Earnings per limited partner unit:
Common unit (basic and diluted) (in USD per share)
$ 0.35
$ 0.16
Weighted average number of limited partner units outstanding:
Common units (basic and diluted) (in shares)
86,997,590
86,997,590
v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:
Net income
$ 30,146
$ 13,744
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense
15,223
15,244
Amortization of debt issuance costs
508
551
Deferred income tax expense
(18)
326
Loss on extinguishment of debt
3,501
0
Decrease (increase) in:
Accounts receivable
(11,381)
(10,387)
Accounts receivable—related party
4,998
505
Inventories
3,517
(1,001)
Advances due from related parties
108
160
Other non-current assets, other current assets and prepaid expenses
(847)
648
Increase (decrease) in:
Accounts payable
1,597
(4,850)
Accounts payable—related party
(216)
260
Other payables, accruals, and current liabilities
(277)
180
Accrued interest
(2,226)
(378)
Accrued interest—related party
(1,468)
(171)
Net cash provided by operating activities
43,165
14,831
Cash flows from investing activities:
Purchase of property, plant, and equipment
(508)
(1,368)
Net cash used in investing activities
(508)
(1,368)
Cash flows from financing activities:
Proceeds from revolving credit facility
0
62,000
Proceeds from term loan facility
455,000
0
Repayment of revolving credit facility
(16,000)
(30,000)
Repayment of term loan B credit facility
(231,825)
(1,120)
Repayment of term loan facility—related party
(200,000)
0
Repayment of revolving credit facility—related party
0
(35,000)
Debt issuance costs
(8,189)
(136)
Remittance of cash to OCI USA for transferred trade receivables
(9,327)
(112)
Net cash used in financing activities
(10,341)
(4,368)
Net increase in cash and cash equivalents
32,316
9,095
Cash and cash equivalents, beginning of period
16,275
8,080
Cash and cash equivalents, end of period
48,591
17,175
Supplemental cash disclosures:
Cash paid during the period for income taxes
0
0
Cash paid during the period for interest
7,608
5,361
Cash paid during the period for interest—related party
4,936
4,701
Supplemental non-cash disclosures:
Accruals of property, plant and equipment purchases
183
244
Distribution to Unitholders payable
2,523
0
Distribution to Unitholders payable—related party
$ 20,966
$ 0
v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:
Cash and cash equivalents
$ 48,591
$ 16,275
Accounts receivable
43,413
32,032
Accounts receivable—related party
1,505
6,503
Inventories
2,524
6,041
Advances due from related parties
80
188
Other current assets and prepaid expenses
4,823
3,917
Total current assets
100,936
64,956
Property, plant, and equipment, net of accumulated depreciation of $242,273 and $227,050, respectively
543,335
558,206
Other non-current assets
1,468
942
Total assets
645,739
624,104
Current liabilities:
Accounts payable
16,348
14,812
Accounts payable—related party
4,725
14,268
Other payables and accruals
1,415
2,652
Revolving credit facility, net
0
15,977
Current maturities of the term loan facility
4,550
4,480
Accrued interest
176
2,402
Accrued interest—related party
0
1,468
Cash distributions payable
23,489
0
Other current liabilities
2,015
1,150
Total current liabilities
52,718
57,209
Term loan facility, net
442,915
223,428
Term loan facility—related party
0
200,000
Other non-current liabilities
3,128
3,146
Total liabilities
498,761
483,783
Partners’ capital
Common unitholders —86,997,590 issued and outstanding at March 31, 2018 and December 31, 2017
146,978
140,321
General partner’s interest
0
0
Total partners’ capital
146,978
140,321
Total liabilities and partners’ capital
$ 645,739
$ 624,104